References
Jin SE, Jin HE, Hong SS (2015) Targeting l-type amino acid transporter 1 for anticancer therapy: clinical impact from diagnostics to therapeutics. Expert Opin Ther Targets 19:1319–1337
Nawashiro H, Otani N, Uozumi Y, Ooigawa H, Toyooka T, Suzuki T, Katoh H, Tsuzuki N, Ohnuki A, Shima K, Shinomiya N, Matsuo H, Kanai Y (2005) High expression of l-type amino acid transporter 1 in infiltrating glioma cells. Brain Tumor Pathol 22:89–91
Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, Shima K, Matsuo H, Kanai Y, Endou H (2006) l-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 119:484–492
Haining Z, Kawai N, Miyake K, Okada M, Okubo S, Zhang X, Fei Z, Tamiya T (2012) Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas. BMC Clin Pathol 12:4
Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, Giannini C, Laack NN, Parney IF, Lowe VJ, Brinkmann DH, Sarkaria JN (2013) The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. J Neurooncol 111:11–18
Habermeier A, Graf J, Sandhöfer BF, Boissel JP, Roesch F, Closs EI (2015) System l amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-l-tyrosine (FET). Amino Acids 47:335–344
Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC (2016) Response assessment in neuro-oncology working group and European association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol 18:1199–1208
Filss CP, Cicone F, Shah NJ, Galldiks N, Langen KJ (2017) Amino acid PET and MR perfusion imaging in brain tumors. Clin Transl Imaging 5:209–223
Cicone F, Clerico A, Minniti G, Paiano M, Carideo L, Scaringi C, Langen KJ, Scopinaro F (2016) (18)F-DOPA positron emission tomography in medulloblastoma: 2 case reports. World Neurosurg 93:490.e7–490.e11
Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho YJ, Pomeroy SL, Korshunov A, Lichter P, Taylor MD, Pfister SM (2012) Medulloblastomics: the end of the beginning. Nat Rev Cancer 12:818–834
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in the study were in accordance with the standards of the institutional ethical committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent
For this type of retrospective study, formal consent is not required.
Conflict of interest
The authors declare that they have no competing interests.
Funding
The cost of this study was partially defrayed by a Grant from Sapienza University of Rome (Avvio alla Ricerca 2015, protocol# C26N15RM38).
Rights and permissions
About this article
Cite this article
Cicone, F., Minniti, G., Oliva, M.A. et al. Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma. Brain Tumor Pathol 34, 179–181 (2017). https://doi.org/10.1007/s10014-017-0296-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10014-017-0296-6